The Asia Pacific Uveitis Treatment Market would witness market growth of 6.7% CAGR during the forecast period (2019-2025). Anti-inflammatory medications are available in the form of eye drops, pills, or injection medicine. Anti-inflammatory medication eye drops may not penetrate well to the back of the eye, so this form of treatment is not recommended for posterior uveitis. In the case of intermediate or posterior uveitis, and if topical corticosteroid has not operated, injections or injections of corticosteroids are used to minimize inflammation. On the other hand, the segment of immunotherapy & targeted therapies is projected to see the highest growth in the market due to a rise in demand for ideal therapies for uveitis treatment. In the market for uveitis treatment, there are immunosuppressant medications such as azathioprine, cyclosporine, methotrexate, mycophenolate, and others.
Corticosteroid treatments have predominantly shaped the bulk of the uveitis market. The Asia-Pacific uveitis market, which is AbbVie's Humira (adalimumab), currently only provides one targeted treatment. The late-stage uveitis pipeline consists of the Opsiria of Santen and the CLS-TA of Clearside Biomedical, which is predicted to be extremely lucrative and solve some of the unmet needs. These new drugs will broaden the options available for treating patients with uveitis and contribute to overall market growth by introducing new therapeutic pathways, including new drug delivery routes and novel, non-corticosteroid drug molecules.
Based on Drug Class, the market is segmented into Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class. Based on Disease Type, the market is segmented into Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online stores. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Uveitis Treatment Market in Asia Pacific is expected to register a CAGR of 6.7% during the forecast period (2019-2025)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.
Scope of the Asia Pacific Uveitis Treatment Market Analysis
Market Segmentation:
By Drug Class
- Anti-inflammatory
- Immunotherapy & Targeted Therapies
- Antimicrobial Drugs
- Other Drug Class
By Disease Type
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Panuveitis
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online stores
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- AbbVie, Inc.
- Alimera Sciences, Inc.
- Enzo Biochem, Inc.
- Amgen, Inc.
- Bausch Health Companies, Inc.
- Clearside Biomedical, Inc.
- EyePoint Pharmaceuticals, Inc.
- Santen Pharmaceutical Co., Ltd.
- TopiVert Ltd.
- Novartis AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Uveitis Treatment Market, by Drug Class
1.4.2 Asia Pacific Uveitis Treatment Market, by Disease Type
1.4.3 Asia Pacific Uveitis Treatment Market, by Distribution Channel
1.4.4 Asia Pacific Uveitis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Uveitis Treatment Market by Drug Class
3.1 Asia Pacific Anti-inflammatory Market by Country
3.2 Asia Pacific Immunotherapy & Targeted Therapies Market by Country
3.3 Asia Pacific Antimicrobial Drugs Market by Country
3.4 Asia Pacific Other Drug Class Market by Country
Chapter 4. Asia Pacific Uveitis Treatment Market by Disease Type
4.1 Asia Pacific Anterior Uveitis Market by Country
4.2 Asia Pacific Posterior Uveitis Market by Country
4.3 Asia Pacific Intermediate Uveitis Market by Country
4.4 Asia Pacific Other Diseases Market by Country
Chapter 5. Asia Pacific Uveitis Treatment Market by Distribution Channel
5.1 Asia Pacific Hospital Pharmacies Market by Country
5.2 Asia Pacific Retail Pharmacies Market by Country
5.3 Asia Pacific Online stores Market by Country
Chapter 6. Asia Pacific Uveitis Treatment Market by Country
6.1 China Uveitis Treatment Market
6.1.1 China Uveitis Treatment Market by Drug Class
6.1.2 China Uveitis Treatment Market by Disease Type
6.1.3 China Uveitis Treatment Market by Distribution Channel
6.2 Japan Uveitis Treatment Market
6.2.1 Japan Uveitis Treatment Market by Drug Class
6.2.2 Japan Uveitis Treatment Market by Disease Type
6.2.3 Japan Uveitis Treatment Market by Distribution Channel
6.3 India Uveitis Treatment Market
6.3.1 India Uveitis Treatment Market by Drug Class
6.3.2 India Uveitis Treatment Market by Disease Type
6.3.3 India Uveitis Treatment Market by Distribution Channel
6.4 South Korea Uveitis Treatment Market
6.4.1 South Korea Uveitis Treatment Market by Drug Class
6.4.2 South Korea Uveitis Treatment Market by Disease Type
6.4.3 South Korea Uveitis Treatment Market by Distribution Channel
6.5 Singapore Uveitis Treatment Market
6.5.1 Singapore Uveitis Treatment Market by Drug Class
6.5.2 Singapore Uveitis Treatment Market by Disease Type
6.5.3 Singapore Uveitis Treatment Market by Distribution Channel
6.6 Malaysia Uveitis Treatment Market
6.6.1 Malaysia Uveitis Treatment Market by Drug Class
6.6.2 Malaysia Uveitis Treatment Market by Disease Type
6.6.3 Malaysia Uveitis Treatment Market by Distribution Channel
6.7 Rest of Asia Pacific Uveitis Treatment Market
6.7.1 Rest of Asia Pacific Uveitis Treatment Market by Drug Class
6.7.2 Rest of Asia Pacific Uveitis Treatment Market by Disease Type
6.7.3 Rest of Asia Pacific Uveitis Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Amgen, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Product Launches and Product Expansions:
7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expense
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
7.9.1 Company Overview
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Recent strategies and developments:
7.10.4.1 Acquisition and Mergers:
7.10.4.2 Approvals:
7.10.5 Research & Development Expense
TABLE 1 Asia Pacific Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 2 Asia Pacific Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 3 Asia Pacific Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 4 Asia Pacific Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 5 Asia Pacific Anti-inflammatory Market by Country, 2015 - 2018, USD Million
TABLE 6 Asia Pacific Anti-inflammatory Market by Country, 2019 - 2025, USD Million
TABLE 7 Asia Pacific Immunotherapy & Targeted Therapies Market by Country, 2015 - 2018, USD Million
TABLE 8 Asia Pacific Immunotherapy & Targeted Therapies Market by Country, 2019 - 2025, USD Million
TABLE 9 Asia Pacific Antimicrobial Drugs Market by Country, 2015 - 2018, USD Million
TABLE 10 Asia Pacific Antimicrobial Drugs Market by Country, 2019 - 2025, USD Million
TABLE 11 Asia Pacific Other Drug Class Market by Country, 2015 - 2018, USD Million
TABLE 12 Asia Pacific Other Drug Class Market by Country, 2019 - 2025, USD Million
TABLE 13 Asia Pacific Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 14 Asia Pacific Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 15 Asia Pacific Anterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 16 Asia Pacific Anterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 17 Asia Pacific Posterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 18 Asia Pacific Posterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 19 Asia Pacific Intermediate Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 20 Asia Pacific Intermediate Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 21 Asia Pacific Other Diseases Market by Country, 2015 - 2018, USD Million
TABLE 22 Asia Pacific Other Diseases Market by Country, 2019 - 2025, USD Million
TABLE 23 Asia Pacific Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 24 Asia Pacific Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 25 Asia Pacific Hospital Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 26 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 27 Asia Pacific Retail Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 28 Asia Pacific Retail Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 29 Asia Pacific Online stores Market by Country, 2015 - 2018, USD Million
TABLE 30 Asia Pacific Online stores Market by Country, 2019 - 2025, USD Million
TABLE 31 Asia Pacific Uveitis Treatment Market by Country, 2015 - 2018, USD Million
TABLE 32 Asia Pacific Uveitis Treatment Market by Country, 2019 - 2025, USD Million
TABLE 33 China Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 34 China Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 35 China Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 36 China Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 37 China Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 38 China Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 39 China Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 40 China Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 41 Japan Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 42 Japan Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 43 Japan Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 44 Japan Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 45 Japan Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 46 Japan Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 47 Japan Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 48 Japan Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 49 India Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 50 India Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 51 India Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 52 India Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 53 India Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 54 India Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 55 India Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 56 India Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 57 South Korea Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 58 South Korea Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 59 South Korea Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 60 South Korea Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 61 South Korea Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 62 South Korea Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 63 South Korea Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 64 South Korea Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 65 Singapore Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 66 Singapore Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 67 Singapore Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 68 Singapore Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 69 Singapore Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 70 Singapore Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 71 Singapore Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 72 Singapore Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 73 Malaysia Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 74 Malaysia Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 75 Malaysia Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 76 Malaysia Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 77 Malaysia Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 78 Malaysia Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 79 Malaysia Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 80 Malaysia Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 81 Rest of Asia Pacific Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 82 Rest of Asia Pacific Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 83 Rest of Asia Pacific Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 84 Rest of Asia Pacific Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 85 Rest of Asia Pacific Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 86 Rest of Asia Pacific Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 87 Rest of Asia Pacific Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 88 Rest of Asia Pacific Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 89 Key information – AbbVie, Inc.
TABLE 90 Key Information – Alimera Sciences, Inc.
TABLE 91 key information – Enzo Biochem, Inc.
TABLE 92 Key Information – Amgen, Inc.
TABLE 93 key information – Bausch Health Companies, Inc.
TABLE 94 Key Information – Clearside Biomedical, Inc.
TABLE 95 Key Information – EyePoint Pharmaceuticals, Inc.
TABLE 96 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 97 Key Information – Topivert Ltd.
Table 98 Key Information – Novartis AG
List of Figures
FIG 1 Methodology for the research